Healthcare: Cancer is a heterogeneous and multifactorial disease. Among multiple factors, it may be caused by errors, or ...

The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers focusing on maintaining ...

The global market for cancer-focused genetic testing services is on a transformative growth trajectory, with projections estimating a market size of USD 8,472.70 million by 2024, and an expected ...

QUT scientists have uncovered functionality of a genetic variant in the prostate specific antigen (PSA) gene to improve the current diagnostic test to help distinguish aggressive from non-aggressive ...

Mathew Knowles, famous father to Beyoncé and Solange, isn't talking about music or the entertainment industry these days, but ...

The past decade has witnessed a rapid expansion of genetic tests, including new instruments to inform patients who have been ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

Genetic testing, including germline and somatic, is vital for prostate cancer prognosis and personalized treatment strategies. PARP inhibitors, targeting BRCA mutations, are a promising therapy for ...

Relevant genes to test for hereditary prostate cancer include ATM, BRCA1, BRCA2, CHEK2, HOXB13, and TP53, according to the guidelines. For all four cancer types included in these guidelines, NCCN also ...

October is Breast Cancer Awareness Month, and a central Kentucky mother and daughter are sharing their story to help others.

The luncheon, Tie the Ribbon, in its 15th year raises awareness and draws support for the research institute’s breast and ...